Singapore markets close in 6 hours 7 minutes

NovoCure Limited (NVCR)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
12.05-0.41 (-3.29%)
At close: 04:00PM EDT
12.06 +0.01 (+0.08%)
After hours: 07:37PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 1.33B
Enterprise value 1.02B
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)2.60
Price/book (mrq)3.68
Enterprise value/revenue 2.00
Enterprise value/EBITDA -5.75

Trading information

Stock price history

Beta (5Y monthly) 0.43
52-week change 3-80.51%
S&P500 52-week change 321.61%
52-week high 383.60
52-week low 310.87
50-day moving average 314.86
200-day moving average 318.69

Share statistics

Avg vol (3-month) 31.31M
Avg vol (10-day) 31.09M
Shares outstanding 5107.09M
Implied shares outstanding 6107.09M
Float 897.55M
% held by insiders 11.67%
% held by institutions 185.87%
Shares short (28 Mar 2024) 45.01M
Short ratio (28 Mar 2024) 43.16
Short % of float (28 Mar 2024) 46.51%
Short % of shares outstanding (28 Mar 2024) 44.68%
Shares short (prior month 29 Feb 2024) 45.64M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin -40.65%
Operating margin (ttm)-33.64%

Management effectiveness

Return on assets (ttm)-12.09%
Return on equity (ttm)-51.53%

Income statement

Revenue (ttm)509.34M
Revenue per share (ttm)4.79
Quarterly revenue growth (yoy)4.20%
Gross profit (ttm)N/A
EBITDA -216.46M
Net income avi to common (ttm)-207.04M
Diluted EPS (ttm)-1.95
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)910.62M
Total cash per share (mrq)8.5
Total debt (mrq)604.47M
Total debt/equity (mrq)166.75%
Current ratio (mrq)5.78
Book value per share (mrq)3.38

Cash flow statement

Operating cash flow (ttm)-73.34M
Levered free cash flow (ttm)-10.2M